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Twenty organs from healthy adult mice were tested for plasminogen activator activity. All were positive 
although specific activities varied 200-fold. Tissues with high activity were lung, uterus, brain and kidney. 
Endocrine glands were moderately rich in activator activity, and lymphoid tissues were poor. Molecular 
mass characterization was carried out. Two enzymatic forms were observed in all twenty organs: a 70 kDa 
form similar to human tissue plasminogen activator and a 48 kDa form analogous to mouse urokinase. 
Plasminogen activator Electrophoresis (Mouse organ) 
1. INTRODUCTION 
Plasminogen activators (PA) are highly specific 
proteinases which convert inactive plasminogen in- 
to active plasmin, a broad spectrum proteolytic en- 
zyme. In humans, two types of PA are found: the 
tissue-type plasminogen activator (tPA) primarily 
purified from uterus [l] and the urokinase type 
(uPA) present in abundance in urine [2]. Both 
types are detected in many other tissues and fluids. 
Tumor cells frequently overproduce one or the 
other type of PA. These two proteins are im- 
munologically distinct, differ in molecular mass, 
and are encoded by different genes [3,4]. 
Although numerous data concerning human PA 
are available, there are only a few reports dealing 
with PAS of other mammals. Our interest was 
focused on mouse. In this animal, PA has been 
observed in a viral transformed fibroblast cell line 
[5] and in a few embryonic and adult tissues [6,7]. 
The objective of this study was to quantify the PA 
activity in healthy adult organs. To identifv the en- 
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zymes implicated we used the technique of gel elec- 
trophoresis with in situ zymography. Molecular 
mass characterization could be done for each 
tissue, even with quantities equivalent o 50 pg PA. 
2. MATERIALS AND METHODS 
2.1. Tissue extracts 
3-month-old BALB/c mice were killed by cer- 
vical dislocation. Organs were dissected out asep- 
tically and freed of connective tissue and fat. They 
were then rinsed in a large volume of cold PBS 
(Dulbecco’s phosphate-buffered saline without 
calcium or magnesium) to eliminate blood con- 
tamination. Organs or fragments were gently dried 
on tissue paper and weighed. They were then 
minced with scissors and homogenized in 10 
vols/wt of cold sterile PBS containing 0.5% Triton 
X-100 using a Dounce homogenizer (25 strokes of 
a loose-fitting pestle at 4°C). The lysates were cen- 
trifuged for 15 min at 3OOOxg, and the super- 
natants stored at -20°C. 
2.2. PA assay 
10 ~1 homogenate (or an appropriate dilution) 
were assayed for plasminogen-dependent fibrino- 
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lytic activity using ‘*‘I-fibrin coated Linbro (24- 
well) tissue culture dishes. Bovine fibrinogen was 
purifed according to Mosesson [8] and radiola- 
belled as described by Goldfine [9] (spec.act. 10’ 
cpm/mg). Prior to use, the fibrinogen-coated 
dishes were incubated for 2 h with thrombin (0.03 
U/ml) in PBS at 37°C to convert fibrinogen to 
fibrin, and then washed twice with cold sterile 
PBS. Solubilization of lz51-fibrin by tissue extracts 
in the presence of 8 fig/ml human plasminogen was 
determined. The plasminogen was purified by 
lysine-Sepharose chromatography [lo]. Results are 
expressed in terms of equivalent urokinase activity 
by comparison with a urokinase standard (Choay, 
France). Total radioactivity was determined by in- 
cubating fibrin-coated wells with trypsin (25 
pg/ml). Solubilization of radioactivity was linear 
with urokinase concentration up to 3 mU per assay 
in a 31% h incubation. Background release of 
radioactivity by plasminogen was 2-S% of total 
radioactivity, and 1 mU urokinase solubilized an 
additional 15% of the radiolabelled fibrin. Radio- 
activity released in duplicate assays varied by 10% 
or less. 
2.3. Gel electrophoresis and zymography of PA 
Samples were electrophoresed under non-re- 
ducing conditions in 11% SDS-polyacrylamide slab 
gels supplemented with plasminogen (20 pg/ml) 
and gelatin (2 mg/ml) at 4°C [l 11. After electro- 
phoresis, the gels were soaked in 1.25% Triton 
X-100 for 3 h and further incubated in 0.1 M Tris- 
HCl, pH 8.1, at 37°C overnight. Finally, they were 
fixed and stained. 
3. RESULTS AND DISCUSSION 
3. I. Quantification of PA activity in organs of 
healthy adult mice 
Twenty organs were tested for PA activity using 
the ‘251-labelled fibrin plate method. The results 
are summarized in table 1. All organs were positive 
although with various levels of activity. Specific 
activities varied 200-fold with the high ‘producer 
organs’ being lung, uterus, brain and kidney. 
However, one must consider that the apparent 
level of PA is, in fact, the result of several interac- 
tions. Specific inhibitors of PAS are sometimes 
present [12] and may decrease the observed activi- 
ty. From another point of view, PA may be syn- 
thesized as an inactive proenzyme, especially the 48 
kDa form [13], and will not be taken into account 
in this assay. Consequently, the results observed 
represent a minimal estimation of PA activity in 
the organ tested. The great abundance of PA(s) in 
brain was rather unexpected since these nzymes 
have been frequently associated with cell migration 
or tissue remodeling. PAS were previously ob- 
served in embryonic or neonatal brain but this 
phenomenon was attributed to neuronal migration 
[14, 151. To verify and extend our observation, the 
mouse central nervous system was dissected in 4 
parts: cerebral cortex, cerebellum, diencephalon 
plus brain stem, and pituitary gland. PA assays 
showed great differences (table 1) with dien- 
cephalon plus brain stem being 7-times richer than 
cerebellum. Cerebral cortex and pituitary gland 
were intermediate. These results clearly show that 
PA is an important enzymatic activity of adult 
healthy brain although we cannot actually point 
out which cell type is responsible for this activity. 
A group of moderately rich tissues was found 
which have activities lo-20-times less than that 
observed in lung. All 4 endocrine glands tested fell 
in this group: adrenal, testis, thyroid and ovary. 
These results may be compared to those of Virji et 
al. [16] demonstrating the presence of PA in the 
islets of Langerhans. The authors suggested that 
the PA/plasmin system might play a part in the 
conversion of proinsulin to the active hormone. In 
the endocrine glands tested here, 3 out of 4 secrete 
steroid hormones or adrenergic compounds. PAS 
have been shown to be involved in both ovulation 
[ 171 and spermatogenesis [ 181. Their role in adrenal 
and thyroid remains unknown and it is possible 
that they could be involved in the endocrine secre- 
tion process itself. Connective tissue was also a 
moderate producer of PA. Concerning muscle, a 
great difference (Qfold) was observed between 
heart and skeletal muscle (table 1). 
Finally, organs that are considered to be poor 
producers contained PA at levels 40-200-times 
below that of lung. Among these are liver, pan- 
creas, and all lymphoid tissues tested: thymus, 
spleen and lymph nodes. A transformed T cell line 
(BW) was totally negative. These results are in ap- 
parent contradiction with numerous publications 
dealing with the secrtion of PA by stimulated 
macrophages [ 19,201, polymorphonuclear leuco- 
cytes [21], B lymphocytes [22], and natural killer 
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Table 1 
Distribution of plasminogen activators in murine tissues 
Mouse organs PA Molecular forms 
activity 
(Ufmg) 70 kDa 48 kDa Others 
Lung 
Uterus 
Diencephalon + cerebral 
stem 
Cerebrum 
Kidney 
Pituitary gland 
Adrenal gland 
Testis 
Cerebellum 
Thyroid 
Heart 
Connective tissue 
Ovary 
Pancreas 
Liver 
Oesophagus 
Thymus 
Spleen 
Skeletal muscle 
Lymph node 
Bladder 
Aorta 
Ureter 
Urine (U/ml) 
2.190 
1.390 
1.380 
0.623 
0.531 
0.487 
0.276 
0.265 
0.191 
0.184 
0.150 
0.130 
0.102 
0.057 
0.046 
0.035 
0.032 
0.027 
0.027 
0.022 
0.023 
0.019 
0.011 
8.250 
+ + 110 kDa (traces) 
+ (maj) + 110 kDa (traces) 
+ (maj) + 
+ (maj) + 
+ + 
+ (maj) + 
+ + 
+ 
+ (maj) 1 
+ + 
+ + 
+ + 
+ (doublet) + 
+ + 
+ + 
+ + 
+ (doublet) + 
+ f 
+ + 
+ + 
+ (doublet) + 
+ + 
+ + 
+ 
(traces) 
(traces) 
(maj) 
(traces) 
(traces) 
(maj) 110 kDa (traces) 
110 kDa (traces) 
110 kDa {traces) 
110 kDa (traces) 
Tissues were removed, weighed and lysed in PBS containing 0.5% Triton X-100. 
Lysates or dilutions were assayed by the ‘2sI-labelled fibrin plate method for 3% 
h in the presence of plasminogen. Control incubations were also done in the 
absence of plasminogen to detect possible non-specific proteases. All organs 
tested were negative for such contamination atthe dilutions elected except pan- 
creas and thyroid in which radioactive r lease represented 3.2 and 7.6% of total 
solubilization, respectively. These values were subtracted to evaluate PA activi- 
ty. Molecular masses were characterized as described in fig.1. 
ly~phoc~~ [23]. Three possible explanations may 
be suggested for this difference: (i) unstimulated 
lymphoid cells may spontaneously secrete low 
levels of PA; (ii) they may synthesize specific in- 
hibitors [24,25]; and/or (iii) the cultured cells may 
give divergent results from their corresponding 
normal tissues due to the culture conditions 
[26,27]. 
3.2, Characterization of PA produced in different 
tissues 
Two forms of mouse PA have previously been 
distinguished on the basis of their app~ent mole- 
cular mass: a 48 kDa PA purified from MSV in- 
fected 3T3 cells [5] which is analogous to mouse 
urokinase and a higher-molecular-mass activator 
of 70-80 kDa observed in embryonic tissues [28]. 
The latter can be inhibited by antibodies raised 
against human melanoma PA. Our aim was to, 
search for other possible PA(s) and to determine 
the distribution of the already known types of PA. 
The activity of these enzymes can still be assayed 
after SDS-polyacrylamide gel electrophoresis as 
long as non-rousing condiffons are maintains 
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Fig. 1. Zymography of electrophoretic gels. Samples corresponding to 5 mU plasminogen activators nd adjusted to I % 
SDS (without any reducing agents) were loaded on 0.7 mm SDS-polyacrylamide slab gels supplemented with 
plasminogen and gelatin. Migration was performed at 4°C. Gels were rinsed in 1.25% Triton X-100 and further in- 
cubated at 37°C in 0.1 M Tris, pH 8.1. They were finally stained with Coomassie blue. Parallel gels were run in each 
case without plasminogen to detect non-specific proteases. One such ptotease is visible in kidney. 
during the ele~trophoresis. The 20 organs were 
therefore analyzed using these conditions and 
typical results are shown fig.1 and table 1. All of 
the tissues exhibited 2 types of PA: the 48 kDa 
form and a higher-molecular-mass form migrating 
to the same position as the lighter form of the 
human tPA doublet (70 kDa). The proportion be- 
tween the 2 types varied from one tissue to 
another. At the 2 extremes, kidney contained a 
majority of the 48 kDa form while brain contained 
a very large predominance of the 70 kDa form 
(2 90% of the activity as tested by inhibition by in- 
creasing amounts of anti-human tPA im- 
munogIobuIins). Occasionally, trace amounts of a 
100-l 10 kDa form were observed in several tissues. 
Similar high-molecular-mass forms have been 
previously observed in human cells and 
demonstrated to be a complex of PA with a 
specific inhibitor [29]. 
In conclusion, the proteolytic cascade of PA/ 
plasmin seems to be widely used in organs of 
healthy adult mice. As in humans, only 2 types of 
PAS are apparent: mouse tPA showing an identical 
molecular mass to that of human tPA (70 kDa), 
and mouse urokinase (48 kDa) with a different 
molecular mass from human uPA. Both types are 
observed in all the organs tested although in 
variable proportion. Of particular interest is the 
presence of large amounts of mouse tPA in aduh 
brain and to a lesser extent of both forms in en- 
docrine glands. 
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